The lack of strong correlation between SMN protein levels, and SMN2 copy number or transcript levels in SMA patients suggests that there may be significant modulation of SMN at the posttranscriptional level.
← all excerpts
Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study.
1
—
—